2021-01-05,Artelo Biosciences to Present at the H.C. Wainwright BioConnect 2021 Conference
2020-12-09,Artelo Biosciences Files Patent Application for New Formulation of ART27.13
2020-12-08,Artelo Biosciences to Present at The 13th Annual LD Micro Main Event Conference on December 15th
2020-12-02,"Artelo Biosciences Announces Appointment of Senior Pharmaceutical Executive Gregory R. Reyes, M.D., Ph.D., to Board of Directors"
2020-11-23,Artelo Biosciences and University of Western Ontario Awarded Research Grant by Mitacs
2020-11-16,Artelo Biosciences Announces Clinical Trial Authorization to Commence Cancer Appetite Recovery Study for the Treatment of Cancer-Related Anorexia and Weight Loss
2020-11-11,Artelo Biosciences to Present at the Virtual Fall Investor Summit on November 18th
2020-11-04,Artelo Biosciences Reports Fourth Quarter and Fiscal 2020 Year-End Financial Results and Provides Business Update
2020-11-02,"Did Artelo Biosciences, Inc. (NASDAQ:ARTL) Insiders Buy Up More Shares?"
2020-10-21,Artelo Biosciences Files Patent on Use of Fatty Acid Binding Protein 5 Inhibitors for Treating Psychological Disorders
2020-10-14,"Artelo Biosciences, Inc. Announces Closing of $7.6 Million Underwritten Public Offering and Full Exercise of Underwriters Option"
2020-10-09,"Artelo Biosciences, Inc. Announces Pricing of $6.6 Million Upsized Underwritten Public Offering"
2020-09-29,Artelo Biosciences Receives Ethics Approval to Commence its Cancer Appetite Recovery Phase I/II Clinical Study (CAReS) of ART27.13 for the Treatment of Cancer-Related Anorexia
2020-09-11,Artelo Biosciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 15th
2020-09-10,Artelo Biosciences to Participate in Two Keynote Panels at 3rd Annual International Cannabinoid Derived Pharmaceutical Summit
2020-08-31,LD Micro: 360 Companies - Set to Present this Week
2020-08-26,Artelo Biosciences to Present at The LD 500 Virtual Investor Conference on September 1st
2020-08-05,LD Micro Announces Preliminary List of Presenters for the LD-500.
2020-07-14,Artelo Biosciences Reports Third Quarter Fiscal Year 2020 Financial Results and Provides Business Update
2020-06-29,"Artelo Biosciences Expands Stony Brook Commercial License Agreement for FABP5 Platform for Development of Lead Cancer, Pain and Inflammation Compounds"
2020-06-03,Artelo Biosciences to Participate in BIO Digital and The Investor Summit Conferences
2020-06-03,47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th
2020-05-12,Artelo Biosciences Awarded Composition of Matter Patent for Novel CBD Cocrystal
2020-05-06,"Independent Chairperson of the Board Connie Matsui Just Bought 278% More Shares In Artelo Biosciences, Inc. (NASDAQ:ARTL)"
2020-04-14,Artelo Biosciences Reports Second Quarter Fiscal Year 2020 Financial Results and Provides Business Update
2020-03-23,Artelo Biosciences to Present at the Spring Investor Summit on March 25th
2020-03-02,Here's Why We're A Bit Worried About Artelo Biosciences's (NASDAQ:ARTL) Cash Burn Situation
2020-02-24,Artelo Biosciences to Present at Biocoms 10th Annual Global Life Sciences Partnering Conference
2020-02-03,Artelo's stock soars after NCI grant to develop cancer treatment
2020-02-03,Artelo Biosciences Announces NCI Grant of $4.2 Million to Stony Brook University to Advance FABP5 Inhibitor Cancer Program
2020-01-29,Artelo Biosciences to Present at the LSX World Congress in London
2020-01-14,Artelo Biosciences Reports First Quarter Fiscal Year 2020 Financial Results and Provides Business Update
2019-12-09,Artelo Biosciences Announces Appointment of Seasoned Finance and Industry Executive John W. Beck to Board of Directors
2019-11-25,Artelo Biosciences Reports Fourth Quarter and Fiscal Year 2019 Financial Results and Provides Business Update
2019-11-18,Artelo Biosciences Announces Publication of Positive Non-Clinical Fatty Acid Binding Protein 5 Inhibitor Data in Peer-Reviewed Journal
2019-11-14,Artelo Biosciences to Present at the Annual Investival Showcase in London
2019-10-29,Artelo Biosciences Announces Selection of Aptus Clinical Ltd. as Clinical Research Organization for Phase 1b/2a Study of ART27.13
2019-10-22,Artelo Biosciences to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
2019-09-18,Artelo Biosciences Cannabidiol (CBD) Studies Referenced in September Issue of Nature Medicine
2019-09-11,Artelo Biosciences to Present at the Fall Investor Summit in New York City on September 17th
2019-09-04,"What Percentage Of Artelo Biosciences, Inc. (NASDAQ:ARTL) Shares Do Insiders Own?"
2019-07-15,Artelo Biosciences Reports Third Quarter 2019 Financial Results and Provides Corporate Update
2019-07-10,Cannabis stocks dragged down by CannTrusts losses after cannabis seizure
2019-06-25,Artelo Biosciences Announces Closing of $8.0 Million Public Offering and Partial Exercise and Closing of Over-Allotment Option
2019-05-08,"Artelo Biosciences Retains Crescendo Communications, LLC for Investor Relations Services"
2019-01-03,Artelo Biosciences Retains Maxim Group LLC to Provide Financial Advisory and Investment Banking Services
2018-10-09,New Preclinical Cell-Line Data of Artelo Biosciences' ART27.13 Demonstrate Anti-Proliferative Activity in Tumor Models
2018-07-03,Artelo Biosciences Announces Five Year Commitment To Sponsor The Young Investigator Award At The International Cannabinoid Research Society Annual Symposium
